Clinical Trials Directory

Trials / Completed

CompletedNCT01573273

Oxytocin in Cocaine Dependence

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
112 (actual)
Sponsor
Medical University of South Carolina · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Stress is likely involved in relapse to cocaine use. This project will investigate the role oxytocin may play in the stress response in cocaine-dependent men and women and examine how oxytocin may impact brain activity in individuals exposed to cocaine-related cues.

Detailed description

Stress is an important predictor of relapse, and targeting stress-activated pathways may lead to therapeutic advancements in the treatment of substance use disorders. Oxytocin has been shown to promote trust, social bonding, and calmness; however, its potential effects have not been explored in cocaine-dependent individuals. Oxytocin receptors have been localized to brain regions that are activated by drug-paired cues and preclinical studies have shown that oxytocin attenuates the acute and long-term behavioral effects of psychostimulants. However, little is known about the role of oxytocin in mediating the affective response to cocaine-paired cues and associated neural activity in cocaine-dependent men and women. This project is a direct evolution from our previous SCOR-supported research. Our work has progressed from characterizing sex/gender differences in response to social stressors and cocaine cues in cocaine-dependent men and women, to our on-going work evaluating whether stress potentiates cue-induced craving and the impact of hormones on this response. The proposed study will investigate the role of oxytocin in the sex/gender differences in stress response and craving in cocaine-dependent individuals and preliminarily explore its therapeutic potential.

Conditions

Interventions

TypeNameDescription
DRUGOxytocinintranasal administration, 40 IUs
DRUGSalineintranasal administration, 40 IUs

Timeline

Start date
2012-10-01
Primary completion
2017-12-19
Completion
2017-12-19
First posted
2012-04-09
Last updated
2019-03-13
Results posted
2019-03-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01573273. Inclusion in this directory is not an endorsement.

Oxytocin in Cocaine Dependence (NCT01573273) · Clinical Trials Directory